Medtronic MEIC Expands Breast and Cervical Cancer Screenings in Hyderabad

Date:

Share post:

The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.

Driven by Medtronic’s core mission to improve health and strengthen society, this year’s efforts focused heavily on early childhood development and women’s preventive healthcare. MEIC’s initiatives successfully strengthened 10 AnganwadiCentres, expanding educational access and child health screening programs across the region.

A major milestone of the program was expanding access to breast and cervical cancer awareness and screening services to more than 1,800 women in underserved areas across Hyderabad. By emphasizing the importance of early detection, these targeted interventions helped foster safer, more supportive environments for local families while bringing critical, preventative medical resources directly to those in need.

“Through sustained community engagement, we remain committed to creating meaningful impact beyond our workplace and contributing to healthier communities,” the center stated. Moving forward, MEIC will continue to leverage community partnerships to bridge healthcare gaps and advance long-term welfare.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...